Overview

Alteplase for Percutaneous Treatment of Loculated Abdominopelvic Abscesses

Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
Intracavitary injection of low dose alteplase into loculated abdominopelvic abscesses will reduce the duration of percutaneous drainage and increase the proportion of successful drainages.
Phase:
Phase 2
Details
Lead Sponsor:
Kaiser Permanente
Collaborator:
Genentech, Inc.
Treatments:
Tissue Plasminogen Activator